PKI Stock Recent News

Moderna Inc. MRNA, -4.99% said Wednesday that Chief Financial Officer David Meline will retire, effective Sept. 6. Moderna shares fell 0.6% in premarket trading.

CNBC's Jim Cramer spoke with PerkinElmer CEO Prahlad Singh on Thursday's episode of "Mad Money."

The "Mad Money" host offered investors a list of Covid-era winning stocks he says are continuing to perform well on Monday's episode of the show.

Parkland Corporation (OTCPK:PKIUF) Q2 2022 Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Valerie Roberts - Director, IR Bob Espey - President & CEO Marcel Teunissen - CFO Conference Call Participants Kevin Chiang - CIBC Ben Isaacson - Scotiabank Steve Hansen - Raymond James Derek Dley - Canaccord Neil Mehta - Goldman Sachs Matthew Weekes - IA Capital Markets Michael Van Aelst - TD Securities Peter Sklar - BMO Capital Markets Luke Davis - RBC Operator Good morning. My name is Pam and I will be your conference operator today.

PerkinElmer, Inc. (NYSE:PKI ) Q2 2022 Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants Stephen Willoughby - VP, IR Prahlad Singh - CEO, President & Director James Mock - SVP & CFO Conference Call Participants Daniel Arias - Stifel, Nicolaus & Company Derik De Bruin - Bank of America Merrill Lynch Vijay Kumar - Evercore ISI Jack Meehan - Nephron Research Liza Garcia - UBS Paul Knight - KeyBanc Capital Markets Catherine Schulte - Robert W. Baird & Co. Joshua Waldman - Cleveland Research Company Operator Good morning.

It seems to have become a new trend: big, multi-divisional companies are paring down to become more focused. On Aug. 1, PerkinElmer Inc. ( PKI , Financial) hopped on the bandwagon, announcing it plans to divest its analytical, food and enterprise services businesses.

PerkinElmer posted its Q2 earnings with a solid set of results that prompted an upward revision of FY22 guidance. Also announced was New Mountain Capital's intention to buy a carve-out of businesses from PKI on a $2.45 billion consideration.

PerkinElmer's (PKI) second-quarter results benefit from a solid performance at Discover & Analytics Solutions business.

PerkinElmer Inc said it will sell some of its businesses along with the brand name to private equity firm New Mountain Capital for up to $2.45 billion in cash, as it looks to focus on its life sciences and diagnostics businesses under a new name.

PerkinElmer (PKI) delivered earnings and revenue surprises of 14.29% and 2.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?